Dr. Luca Gianaroli is specialist in Reproductive Medicine since the early Eighties. He is the Scientific Director of IIIRM SA in Lugano, Switzerland. In the mid-Ninties, he was the founder of the first Italian day surgery clinic dedicated to Assisted Reproduction. 

Throughout his clinical career he performed more than 6,000 surgical procedures for infertility and he supervised more than 30,000 IVF/ICSI/PGT cycles at several clinics in Italy and abroad. 

Dr. Gianaroli has always been an active member of several national and international scientific societies in which he has covered and currently covers roles of primary importance.

In 2009-2011, he served as Chairman of the European Society of Human Reproduction and Embryology (ESHRE).

In 2014 he was appointed as Fellow ad eundem of the Royal College of Obstetricians and Gynaecologists.
In 2017, he was one of the founders of the Fondazione PMA.Italia (PMA.Italia Foundation), of which he is currently the Vice-President. From 2016 to 2021 he served as coordinator of the Steering Committee of the ESHRE ART Centre Certification Program.

At present, he is the Director of Global Educational Programs of the International Federation of Fertility Societies (IFFS).

With reference to academic activities, throughout his professional career Dr. Gianaroli collaborated with several universities in Italy and abroad . He has served as Honorary Professor at the School of Biosciences of the University of Kent from  2014. In 2014 he obtained the Italian Abilitazione Scientifica Nazionale (National Scientific License) as Full Professor, which was renewed in 2020.

Dr. Gianaroli is author of more than 300 papers and as of the date of this biosketch his H-index is 85 (Google Scholar).

Anuja Dokras, MD, MHCI, PhD
Director, Penn Medicine PCOS Center

Anuja Dokras, MD, MHCI, PhD is the Executive Director of the Women's Health Center for Clinical Innovation (WHCCI) and the Founder’s Professor of Women’s Health in the Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility at the University of Pennsylvania, Philadelphia. She is also the Director of the PENN Polycystic Ovary Syndrome (PCOS) Center, a multi-disciplinary center providing care to adolescents and people with PCOS across the lifespan. Dr. Dokras brings to this role her extensive research experience in translational medicine and clinical trials with a focus on understanding cardiometabolic risk and mental health co-morbidities associated with PCOS. Dr. Dokras is an internationally recognized NIH-funded researcher, global patient advocate and educator. She was the past President and is the current Executive Director of the international Androgen Excess (AE)-PCOS society. She is on the senior editorial team of Endocrine Reviews and Fertility & Sterility and is co-editor of the textbook Yen and Jaffe's Reproductive Endocrinology. She received her training in obstetrics, gynecology and reproductive endocrinology at Yale New Haven Hospital, a master’s in Healthcare Innovation (MHCI) from the University of Pennsylvania, and a Doctor of Philosophy from the University of Oxford.

Ben (Willem) Mol is Professor of Obstetrics and Gynaecology at Monash University. Since his arrival in Australia in 2014, Ben holds continuous NHMRC funding, including a prestigious investigator grant, and has been recognized as a very productive (Nature) and well cited (The Australian) author.

During his time in Australia, Ben has worked on clinical trial capacity in women’s health at Monash. He developed extensive relations with Asian universities, resulting in large randomised clinical trials. Ben is also involved in many Individual Participant Data Meta-Analysis, in which on many topics in Obstetrics and in Reproductive Medicine data of randomised clinical trials performed worldwide are brought together. Recently, Ben has worked also on systems to detect data-fabrication in RCTs.

His professional adage is 'A day without randomisation is a day without progress.'

Dr. Ranjith Ramasamy is a renowned American urologist and medical researcher specializing in male infertility, sexual dysfunction, and hypogonadism. He currently serves as a consultant urologist at Jumeirah American Clinic in Dubai, UAE, and previously held the position of Director of Male Reproductive Medicine and Surgery at the University of Miami's Miller School of Medicine.  

With over 500 peer-reviewed publications and several book chapters, Dr. Ramasamy has significantly contributed to the fields of testosterone deficiency, regenerative therapies, erectile dysfunction, and prostate cancer. His pioneering research includes studies on the impact of COVID-19 on male fertility and erectile function.

Dr. Ramasamy's expertise encompasses microsurgical procedures such as vasectomy reversal, varicocelectomy, and penile prosthesis implantation. He has received numerous accolades, including the Gold Cystoscope Award from the American Urological Association in 2023 and the Ira and Ester Rosenwaks New Investigator Award from the American Society for Reproductive Medicine in 2020.